Presentations from the UroCancer Interdisciplinary Forum

Session 1: Health: Exercise, Diet, and Drugs

Health: Exercise, Diet, and Drugs in Prostate Cancer

Logan Briggs, MD, presented this lecture during the UroCancer Interdisciplinary Forum on June 15, 2026.

Session 2: Is PSA Screening Still Broken — or Finally Fixed?

History and Challenges of Early Detection of Prostate Cancer

E. David Crawford, MD, presented this lecture during the UroCancer Interdisciplinary Forum on June 15, 2026.

Is PSA Screening Still Broken or Finally Fixed?

Sean P. Collins, MD, PhD, presented this lecture during the UroCancer Interdisciplinary Forum on June 15, 2026.

Session 3: Can Imaging Replace Biopsy in Selected Patients?

Can Imaging Replace Biopsy in Selected Prostate Cancer Patients?

Sherief Gamie, MD, PhD, presented this lecture during the UroCancer Interdisciplinary Forum on June 15, 2026.

Session 4: State-of-the-Art Immunotherapy in Prostate and Bladder Cancer

Immunotherapy When Nothing Else Works: Rational or Irrational Approach?

Susan F. Slovin, MD, PhD, presented this lecture during the UroCancer Interdisciplinary Forum on June 15, 2026.

Session 5: State-of-the-Art: Is Testosterone the King?

State-of-the-Art: Is Testosterone the King?

Abraham Morgentaler, MD, FACS, presented this lecture during the UroCancer Interdisciplinary Forum on June 15, 2026.

Session 6: Highlights of AUA, GU ASCO, ASCO, and ASTRO

Highlights of AUA, GU ASCO, ASCO, and ASTRO

Hanan Goldberg, MD, MSc, presented this lecture during the UroCancer Interdisciplinary Forum on June 15, 2026.

Top 10 ASTRO 2025 Studies: Prostate and Bladder Cancer Highlights

Sherief Gamie, MD, PhD, presented this lecture during the UroCancer Interdisciplinary Forum on June 15, 2026.

Session 7: How Aggressive Should We Be in Oligometastatic Disease?

How Aggressive Should We Be in Oligometastatic Disease?

Hanan Goldberg, MD, MSc, presented this lecture during the UroCancer Interdisciplinary Forum on June 16, 2026.

Session 8: Are We Overusing Combination Therapy in mHSPC?

Are We Overusing Combination Therapy in mHSPC?

Marijo Bilusic, MD, PhD, presented this lecture during the UroCancer Interdisciplinary Forum on June 16, 2026.

Session 9: What Comes After ARPI + RLT Failure?

Treatment after AR Pathway Inhibition (ARPI) + Radioligand Therapy (RLT)

Andrew Hahn, MD, presented this lecture during the UroCancer Interdisciplinary Forum on June 16, 2026.

Session 10: How Should Germline/Somatic Testing Change Practice?

Germline and Somatic Testing in Prostate Cancer

Gennady Bratslavsky, MD, presented this lecture during the UroCancer Interdisciplinary Forum on June 16, 2026.

Session 11: How Do We Protect Quality of Life in the Era of Intensification?

How Do We Protect Quality of Life in the Era of Intensification?

Andrew Hahn, MD, presented this lecture during the UroCancer Interdisciplinary Forum on June 16, 2026.

Session 12: Strategic Roundtable

Advances in Prostate Cancer Diagnosis and Treatment

Sean P. Collins, MD, PhD, presented this lecture during the UroCancer Interdisciplinary Forum on June 16, 2026.

Session 13: APP Integration Into Practice

APP Integration Into Practice

Diane K. Newman, DNP, ANP-BC, FAAN, FAUNA, BCB-PMD, presented this lecture during the UroCancer Interdisciplinary Forum on June 16, 2026.

Bladder Cancer

Session 1: BCG-Unresponsive NMIBCe

Session 2: Bladder Preservation vs. Cystectomy

BCG-Unresponsive NMIBC

Daniel P. Petrylak, MD, presented this lecture during the UroCancer Interdisciplinary Forum on June 16, 2026.

Bladder Preservation vs Cystectomy

Daniel P. Petrylak, MD, presented this lecture during the UroCancer Interdisciplinary Forum on June 16, 2026.

Session 3: Advanced Disease Sequencing

Session 4: Biomarkers

Advanced Disease Sequencing

Daniel P. Petrylak, MD, presented this lecture during the UroCancer Interdisciplinary Forum on June 16, 2026.

Why Biomarkers Matter Now

Adam J. Cole, MD, FS, presented this lecture during the UroCancer Interdisciplinary Forum on June 16, 2026.